Azathioprine therapy for steroid-resistant Henoch-Schönlein purpura: a report of 6 cases

BACKGROUND: A small percentage of children with Henoch-Schönlein purpura (HSP) develop a chronic form of the disease that often requires prolonged corticosteroid therapy. Disease modifying anti-rheumatic agents (DMARDs) or biologics have been successfully used to treat those refractory cases. Azathi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotis, Lampros, Tuttle, Paul V., Baszis, Kevin W., Pepmueller, Peri H., Moore, Terry L., White, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918135/
https://www.ncbi.nlm.nih.gov/pubmed/27333803
http://dx.doi.org/10.1186/s12969-016-0100-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918135/
https://www.ncbi.nlm.nih.gov/pubmed/27333803
http://dx.doi.org/10.1186/s12969-016-0100-x

Ejemplares similares